A loaded hemophilia A drug market is an indication patients in and around it are well-served, but that hasn’t stopped contenders such as Roche’s emicizumab.
Top 25 rare disease brands, by sales
February 15, 2017
3:35 pm
Teva Pharmaceutical Industries’ Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.
Trump administration raises questions for rare-disease drugmakers